Detalhe da pesquisa
1.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606512
2.
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Clin Infect Dis
; 75(6): 1006-1013, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028659
3.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243494
4.
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
Clin Infect Dis
; 73(9): e3496-e3504, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079176
5.
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419566
6.
Six-Month Response to Delamanid Treatment in MDR TB Patients.
Emerg Infect Dis
; 23(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28767036
7.
Retrieving mutation-specific information for human proteins in UniProt/Swiss-Prot Knowledgebase.
J Bioinform Comput Biol
; 5(6): 1215-31, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172926